December 21, 2020
The U.S. Food and Drug Administration (FDA) recently announced that it is investigating Zantac cancer risks after testing of Zantac 150 tablets found the commonly-used heartburn medication contains a carcinogenic chemical up to 26,000 times greater than the FDA’s daily intake limit. The carcinogenic chemical present in Zantac is known as N-nitrosodimethylamine (“NDMA”). NDMA is an industrial chemical used in gasoline, rocket fuel and other petroleum-based industrial products and is a known human carcinogen. Since the 1980s, numerous studies have demonstrated a link between the NDMA in Zantac and cancer.
Mounting evidence also shows that Sanofi and Boehringer Ingelheim, the big pharma companies that make Zantac (ranitidine), concealed the Zantac cancer link from millions of people who took the drug for heartburn, gastric and duodenal ulcers, gastroesophageal reflux disease (GERD), sour stomach, Barrett’s esophagus, acid reflux and other issues. This deception came as the companies made unprecedented profits from Zantac, the first drug to generate $1 billion in sales. With countless people now stricken with cancer after taking Zantac, many are turning to the courts and filing a Zantac lawsuit to hold Sanofi and Boehringer Ingelheim accountable for their reckless disregard for human health and willingness to put profit over people.
Patients (or surviving family members) who took Zantac may be able to file if you suffered:
Each individual case is going to differ in the allowable compensation based on the laws of your state and the facts of your case. In general, however, plaintiffs may be able to receive damages for the following:
During your free consultation, we will go over any other compensation you may be eligible to receive based on the facts of your case.
Contact us today for a Free Consultation
